Literature DB >> 14155155

REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR.

J V HODGE, J A OATES, A SJOERDSMA.   

Abstract

Entities:  

Keywords:  BRAIN; CARBOXY-LYASES; CLINICAL RESEARCH; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FEVER; GUINEA PIGS; HYDRAZINES; MONOAMINE OXIDASE INHIBITORS; NEUROLOGIC MANIFESTATIONS; PHARMACOLOGY; SEROTONIN; TOXICOLOGIC REPORT; TRYPTAMINES; TRYPTOPHAN

Mesh：

Substances：

Year:  1964        PMID： 14155155     DOI： 10.1002/cpt196452149

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  Improved antisaccade performance with risperidone in schizophrenia.

Authors:  J G Burke; M A Reveley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

2.  Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.

Authors:  G Planz; H W Gierlichs; A Hawlina; R Planz; W Stephany; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

3.  The acute effects of oral (--)-tryptophan in human subjects.

Authors:  M H Greenwood; M H Lader; B D Kantameneni; G Curzon
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 4.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.